logo
Special bioanalysis for special populations?
What are the main considerations for bioanalysis of estrogens and androgens in plasma and serum samples from postmenopausal women?
Bioanalysis in special populations
Determination of the antimalarial drug piperaquine in small volume pediatric plasma samples by LC–MS/MS
Challenges in application of bioanalytical method on different populations and effect of population on PK
The importance of choosing the appropriate matrix to validate a bioanalytical method according to the study needs
European Bioanalysis Forum: recommendation on dealing with hemolyzed and hyperlipidemic matrices
Role of dried blood spots in health and disease diagnosis in older adults
Bioanalysis during pregnancy: recent advances and novel sampling strategies
Metabolomics of drugs of abuse: a more realistic view of the toxicological complexity
A sensitive and rapid method for quantification of lacosamide and desmethyl lacosamide by LC–MS/MS
Quantitative determination of free/bound atazanavir via high-throughput equilibrium dialysis and LC-MS/MS, and the application in ex vivo samples
Retrospective monitoring of long-term recreational and dependent cocaine use in toenail clippings/scrapings as an alternative to hair
Generation and application of polyclonal IgY antibodies specific for full-length and nicked prostate-specific antigen
Quantifying vemurafenib in dried blood spots using high-performance LC–MS/MS
Use of generic LC–MS/MS assays to characterize atypical PK profile of a biotherapeutic monoclonal antibody
2014 White Paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 – hybrid LBA/LCMS, ELN & regulatory agencies’ input)
Application of quality by design and statistical quality control concepts in immunoassays